Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Pharma

    Pharma

    interstitial lung disease
    6 August 2024

    lungDx Technology and ILD: White Paper

    “Improperly treated ILD is associated with a poorer quality of life, an increased risk of life-threatening complications and early mortality.” This white paper provides a comprehensive overview of the pathogenesis of interstitial, its diagnosis and monitoring, and available treatment o...

    4 August 2026

    Functional genomic screens and AI: a key partnership for successful therapeutic development

    Join Cambridge Network and the Milner Therapeutics Institute to explore the world of genomics and AI in developing therapies for human disease. ...

    24 July 2024

    Empowering children and young people to become DNA heroes

    D-CYPHR attended Leicester Grammar School STEM fair to highlight how every family can help childhood health research. Children and young people at the school have been involved in D-CYPHR for a while and it was a great chance to bring the project to life. ...

    19 July 2024

    BioResource participant samples used in research discovering major cause of IBD

    BioResource volunteers have contributed to new research from The Francis Crick Institute - in collaboration with UCL and Imperial College London - which discovered a new biological pathway as the principal driver of Inflammatory Bowel Disease (IBD) and related conditions, and which can ...

    18 July 2024

    Ground-breaking study proves AI-driven programme has comparable effectiveness to human-delivered care while using up to 8 times fewer therapist hours

    A new study by ieso Digital Health in collaboration with the and NIHR BioResource reveals that its AI-driven digital programme delivered results comparable to traditional human-led therapy for generalised anxiety. An estimated 1.2 million people in the UK are on waiting lists for NHS me...

    16 July 2024

    Dylan shares his inspiring story on how all families can be part of research

    Dylan reveals how he had major open heart surgery at just 7 years old. He joined the D-CYPHR programme and became a DNA hero to inspire others. ...

    16 July 2024

    New genetic cause of obesity could help guide treatment

    Researchers working with the NIHR BioResource discovered a genetic link between a specific blood group deficiency and obesity. The study identified a genetic variant affecting the SMIM1 gene, leading to higher body weight due to reduced energy expenditure at rest in Vel-negative individ...

    12 July 2024

    Researchers identify a genetic cause of intellectual disability affecting tens of thousands

    Novel study links genetic changes in a non-coding gene called RNU4-2 to neurodevelopmental disorders ...

    14 May 2024

    Over 20,000 people join search for new dementia treatments

    Volunteers at the BioResource have contributed to a study that aims to speed up the development of much-needed dementia drugs. Our Genes & Cognition cohort will enable scientists in universities and industry to involve healthy individuals in clinical trials to test whether new drugs...

    12 May 2024

    Celebrating Research Nurses on International Nurses Day 2024

    Each year, on 12 May, International Nurses Day highlights the fantastic work carried out by nurses worldwide. It is an opportunity to demonstrate the remarkable difference that nursing staff make to many lives. Here at the BioResource, our Research Nurses are at the forefront of recruit...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 49
    • Page 50
    • Current page 51
    • Page 52
    • Page 53
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS